SHP nuclear localization did not differ between statin and non-statin users (57.5% vs. 49.9%, p = 0.27) or between patients with and without type II diabetes mellitus medications (52.3% vs. 51.1%, p = 0.95) (Table S4). This evidence concerns the gene NR0B2 and type 2 diabetes mellitus.